Q82.2
Congenital cutaneous mastocytosis
Clinical Classification Guidelines
Inclusion Terms
- Congenital diffuse cutaneous mastocytosis
- Congenital maculopapular cutaneous mastocytosis
- Congenital urticaria pigmentosa
Excludes Type 1
- cutaneous mastocytosis NOS (D47.01)
- diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
- malignant mastocytosis (C96.2-)
- systemic mastocytosis (D47.02)
- urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
Medical Intelligence & Overview
Congenital cutaneous mastocytosis is a rare skin condition present from birth that involves abnormal growth of mast cells in the skin. Mast cells are a type of immune cell involved in allergic reactions and inflammation. When these cells are abnormally accumulated and activated in the skin, they cause characteristic skin changes and symptoms. This condition is also known by names such as congenital diffuse cutaneous mastocytosis, congenital maculopapular cutaneous mastocytosis, and congenital urticaria pigmentosa. It primarily affects infants and young children and may vary in severity.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the development and regulation of mast cells Inherited factors that lead to abnormal mast cell proliferation from birth Potential environmental influences during pregnancy that could impact immune cell development
Key Symptoms: Skin lesions that are often present at birth or appear early in life Brownish or reddish patches on the skin, which may be raised or flat Dermal thickening or swelling in affected areas Itching and irritation, especially upon skin stimulation like rubbing or exposure to heat Flushing or redness of the skin In some cases, episodes of swelling or hives are triggered by certain stimuli Potential blistering or localized skin reactions
Diagnostic & Treatment
Diagnosis Path: Diagnosis of congenital cutaneous mastocytosis is primarily clinical and based on physical examination. Doctors look for characteristic skin lesions present at or soon after birth. In some cases, skin biopsy may be performed to confirm the increased presence of mast cells through microscopic analysis. Additional tests might include blood tests to evaluate mast cell levels or markers of allergic activity. It is important to distinguish this condition from other skin disorders to ensure accurate diagnosis.
Treatment Protocols: Use of antihistamines to reduce itching and allergic responses Avoiding known triggers such as heat, friction, certain foods, or medications that may activate mast cells Protective skin care to minimize irritation and breakdown Topical corticosteroids to decrease inflammation in affected areas In severe cases, medications to stabilize mast cells or reduce their proliferation may be prescribed by healthcare professionals Regular monitoring to manage and observe symptom progression
Clinical Advice & FAQs
Billing Guidance
Is Q82.2 a billable ICD-10 code?
Yes, Q82.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q82.2?
Clinical documentation must specify the nature of Congenital cutaneous mastocytosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference